Sort
141,003 grants matching “cytokine”
Migratory Properties of CD8 T Cells
$673,706Immune Disease Institute, Inc. · R01 · FY2004 · AI
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
$673,705Tracey McLaughlin · Stanford University · R01 · FY2017 · DK
Pre-exposure Immunologic Health and Linkages to SARS-COV2 Serologic Responses, Endothelial Cell Resilience, and Cardiovascular Complications: Defining the mechanistic basis of high risk endotypes.
$673,696David A. Zidar · Case Western Reserve University · U01 · FY2022 · CA
PD-1 modulation of SIV specific CD4 and CD8 T cell responses
$673,668Francois J Villinger · Emory University · R01 · FY2010 · AI
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer
$673,652Paul J Brindley · George Washington University · R01 · FY2018 · CA
Epigenetic Reprogramming in Atherosclerosis
$673,647Eicke Latz · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · HL
Epigenetic Reprogramming in Atherosclerosis
$673,647Eicke Latz · Univ Of Massachusetts Med Sch Worcester · R01 · FY2018 · HL
Epigenetic Reprogramming in Atherosclerosis
$673,647Eicke Latz · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · HL
Inflammatory Genomics in Human Carotid Artery Disease
$673,643University Of Washington · R01 · FY2003 · HL
An organotypic model recapitulating colon cancer microenvironment and metastasis
$673,627Emina Hui-Na Huang · Cleveland Clinic Lerner Com-Cwru · U01 · FY2018 · CA
Clinical Research on Non-Alcoholic Steatohepatitis
$673,614Naga P. Chalasani · Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2007 · DK
Adoptive MHC-E-Restricted T Cell Therapy for the Treatment of Chronic Hepatitis B Virus Infection
$673,614Benjamin J Burwitz · Oregon Health & Science University · R01 · FY2023 · AI
Central mechanisms of maintenance of orofacial pain after injury
$673,605Ronald Dubner · University Of Maryland Baltimore · R01 · FY2011 · DE
Development of Immunologic therapies against uveitis
$673,604Charles E Egwuagu · National Eye Institute · ZIA · FY2023 · EY
Therapeutics for the chorioretina
$673,604S. Patricia Becerra · National Eye Institute · ZIA · FY2023 · EY
Identifying adolescents at high risk of neurocognitive disorder: Development and validation of a composite risk index
$673,572Amara E Ezeamama · Michigan State University · R01 · FY2021 · NS
Neuro-immune modulation of pain in health and disease
$673,569Christopher Ryan Donnelly · Duke University · R01 · FY2025 · DE
Neuro-immune modulation of pain in health and disease
$673,569Christopher Ryan Donnelly · Duke University · R01 · FY2023 · DE
Mitigation of Radiation-Induced Pulmonary Injury with Nrf2 activator
$673,561Zeljko Vujaskovic · University Of Maryland Baltimore · U01 · FY2014 · AI
Effect of Intra-Articular Steroids on Structural Progression of Knee OA: An RCT
$673,509Timothy E McAlindon · Tufts Medical Center · R01 · FY2010 · AR
Biomarkers of Tissue Tolerance and Behavior in a Rat Model
$673,492Mary F Barbe · Temple Univ Of The Commonwealth · R01 · FY2021 · AR
Role of the Omentum in the Treatment of Morbid Obesity
$673,398Naji N Abumrad · Vanderbilt University · R01 · FY2006 · DK
Autoimmunity in Cardiopulmonary Toxicities from Radiotherapy and Immunotherapy
$673,394Bo Lu · Thomas Jefferson University · R01 · FY2022 · CA
Microbiome-derived Metabolites Linked to Celiac Disease Onset in Infants at Risk
$673,383Alessio Fasano · Massachusetts General Hospital · R01 · FY2020 · DK
A Novel Synthetically Engineered Oral Immunotherapy for Treating Ulcerative Colitis
$673,379Gary Fanger · Rise Therapeutics, Llc · SB1 · FY2024 · DK